India logs 38,667 COVID-19 cases, 478 fatalities in 24 hrs; Kerala continues to drive surge with over 14% positivity rate

-

India saw a single-day rise of 38,667 coronavirus infections, taking the total tally of cases to 3,21,56,493, while the death toll rose to 4,30,732 with 478 fresh fatalities, according to the Union Health Ministry data updated Saturday. The ministry said the country has now reported less than 50,000 daily new cases for 48 consecutive days.

Also, 22,29,798 COVID-19 tests were conducted Friday, taking the cumulative number of tests conducted so far for the detection of coronavirus in the country to 49,17,00,577, while the daily positivity rate was recorded at 1.73 percent. It has been less than 3 per cent for the last 19 days. Cumulatively, 53.61 crore COVID-19 vaccine doses have been administered till Saturday morning.

Here are key data points from today's data 

  • 38,7673 new cases, 478 new deaths, 3,13,38,088 new recoveries,
  • Active cases rise by 2,446, taking the overall number to  3,87,673 (1.21 per cent of the total infections)
  • Case fatality rate stands at 1.34 percent
  • New cases below 40,000 after two days
  • States with the highest daily cases are: Kerala (around 25,000 new cases), Maharashtra (around 6,700 new cases), and Tamil Nadu (around 1,933 cases)
  • Maharashtra reports 158 new deaths, Kerala 114, Odisha 60
  • 11 states/UTs report rise in active cases
  • Difference between new cases reported in the last 7 days and the preceding 7 days in India is -7 percent (world average is +3 percent)
  • 63.81 lakh new vaccinations. 53.61 crore total. 50.32 lakh received their first dose yesterday, 13.49 lakh second dose
  • Daily vaccinations highest in last 18 days
  • 22.3 lakh new tests.
  • Test positivity rate: 1.73 percent (2.04 percent the previous day)
  • Daily tests highest till date (22,29,798)
  • States with highest test positivity rate: Kerala 14.73 percent, Manipur 14.48 percent, Sikkim 11.21 percent

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

India crossed the grim milestone of two crore on May 4 and three crore on June 23.

With inputs from PTI

 



from Firstpost India Latest News https://ift.tt/3iKvFFh
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more